Becton Dickinson (BDX) Stock
Fundamentals
Recent news

BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation
BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation
BDX

Two Recessions Couldn't Stop These 4 Healthcare Stocks From Raising Dividends
Two Recessions Couldn't Stop These 4 Healthcare Stocks From Raising Dividends
BDX

Jim Cramer Calls This Mining Stock an Inflation Hedge “Just as Good as Crypto”
Jim Cramer Calls This Mining Stock an Inflation Hedge “Just as Good as Crypto”
BDX

BDX Completes PREVENT Trial Enrollment for Phasix Mesh Study
BDX Completes PREVENT Trial Enrollment for Phasix Mesh Study
BDX
Technicals
Analyst Ratings
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $3.99 for this quarter. The company has not yet shared when it is announcing earnings.
% positive news of 10 articles
published over the past 14 days
Latest news

BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation
BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation
BDX

Two Recessions Couldn't Stop These 4 Healthcare Stocks From Raising Dividends
Two Recessions Couldn't Stop These 4 Healthcare Stocks From Raising Dividends
BDX

Jim Cramer Calls This Mining Stock an Inflation Hedge “Just as Good as Crypto”
Jim Cramer Calls This Mining Stock an Inflation Hedge “Just as Good as Crypto”
BDX

BDX Completes PREVENT Trial Enrollment for Phasix Mesh Study
BDX Completes PREVENT Trial Enrollment for Phasix Mesh Study
BDX

Buy, Sell, or Hold These 4 Dividend Kings After Earnings: BDX, ED, EMR, PH
Buy, Sell, or Hold These 4 Dividend Kings After Earnings: BDX, ED, EMR, PH
BDX

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.
We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.
BDX

Becton, Dickinson and Company Q3 Earnings Call Highlights
Becton, Dickinson and Company Q3 Earnings Call Highlights
BDX

BD Stock Up in Pre-Market Post Q3 Earnings & Revenue Beat, Margins Down
BD Stock Up in Pre-Market Post Q3 Earnings & Revenue Beat, Margins Down
BDX

Becton Dickinson (BDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Becton Dickinson (BDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
BDX

Becton Dickinson (BDX) Q3 Earnings and Revenues Surpass Estimates
Becton Dickinson (BDX) Q3 Earnings and Revenues Surpass Estimates
BDX
About Becton Dickinson
Becton Dickinson is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. We provide customer solutions that are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving the drug delivery; aiding anesthesiology care; enhancing the diagnosis of infectious diseases and cancers; advancing research and applications; and supporting the management of diabetes.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Thomas E. Polen Jr. | President, CEO & Chairman | 1973 |
| Dr. Michael D. Garrison | Executive VP & President of Medical Segment and BioPharma Systems Segments | 1970 |
| Mr. Michael C. Feld | Executive VP & Chief Revenue Officer | 1981 |
| Mr. Vitor Roque | Executive VP & CFO | 1983 |
| Ms. Elizabeth McCombs | Executive VP & CTO | 1977 |
| Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D. | Senior VP & Chief Scientific Officer | — |
| Ms. Denise Russell Fleming | Executive Vice President & Chief Information Officer | 1971 |
| Mr. Shawn C. Bevec | Senior Vice President of Investor Relations | — |
| Ms. Lanesha T. Minnix J.D. | Executive VP & General Counsel | 1975 |
| Carla Burigatto | Senior VP & Chief Communications Officer | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
Technicals
What the experts say
8 Wall Street Analyst Ratings
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -2.2 | -2.1 | -2.4 | +4.1 | ||||||||
| 2022 | +0.4 | +7.1 | -2.0 | -5.8 | +4.2 | -1.9 | -3.0 | +3.1 | -12.7 | +2.2 | +6.6 | +1.4 |
| 2023 | -1.5 | -7.7 | +6.6 | +7.0 | -8.9 | +6.4 | +6.4 | +0.3 | -7.2 | -1.9 | -6.9 | +2.3 |
| 2024 | -2.7 | -2.8 | +5.2 | -3.9 | -0.7 | -2.1 | +5.1 | +2.7 | -0.4 | -3.3 | -5.7 | +1.8 |
| 2025 | +9.3 | -8.9 | +0.3 | -8.4 | +1.8 | +1.7 | +0.3 | +9.4 | -0.5 | -6.4 | +9.4 | +1.2 |
| 2026 | +4.4 | -12.6 | -10.9 | -4.7 | -1.5 | +4.1 | +8.3 | +10.5 | -4.2 |



